Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Net Margin (2018 - 2025)

Neurogene (NGNE) has disclosed Net Margin for 5 consecutive years, with 2315400.0% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Net Margin rose 231190432.0% year-over-year to 2315400.0%, compared with a TTM value of 106385.19% through Sep 2025, up 10125003.0%, and an annual FY2024 reading of 8016.22%, down 19608764.0% over the prior year.
  • Net Margin was 2315400.0% for Q2 2025 at Neurogene, up from 28491.25% in the prior quarter.
  • Across five years, Net Margin topped out at 2315400.0% in Q2 2025 and bottomed at 2834.05% in Q1 2024.